"Approval Date","Drug Name","Submission","Active Ingredients","Company","Submission Classification *","Submission Status"
"12/01/2017","HIPREXNDA   #017681","SUPPL-18","METHENAMINE HIPPURATE","VALIDUS PHARMS","Labeling","Approval"
"12/01/2017","LEXIVANDA   #021548","SUPPL-40","FOSAMPRENAVIR CALCIUM","VIIV HLTHCARE","Labeling","Approval"
"12/01/2017","LEXIVANDA   #022116","SUPPL-24","FOSAMPRENAVIR CALCIUM","VIIV HLTHCARE","Labeling","Approval"
"12/01/2017","MOZOBILNDA   #022311","SUPPL-18","PLERIXAFOR","GENZYME","Labeling","Approval"
"12/01/2017","CILOSTAZOLANDA  #077021","SUPPL-14","CILOSTAZOL","CASI PHARMS INC","Manufacturing (CMC)","Approval"
"12/01/2017","CILOSTAZOLANDA  #077310","SUPPL-12","CILOSTAZOL","CASI PHARMS INC","Manufacturing (CMC)","Approval"
"12/01/2017","QUETIAPINE FUMARATEANDA  #090757","ORIG-1","QUETIAPINE FUMARATE","ANCHEN PHARMS","","Approval"
"12/01/2017","TALTZBLA   #125521","SUPPL-4","IXEKIZUMAB","ELI LILLY AND CO","","Approval"
"12/01/2017","REPATHABLA   #125522","SUPPL-13","EVOLOCUMAB","AMGEN INC","","Approval"
"12/01/2017","REPATHABLA   #125522","SUPPL-14","EVOLOCUMAB","AMGEN INC","","Approval"
"12/01/2017","MEGESTROL ACETATEANDA  #204688","ORIG-1","MEGESTROL ACETATE","BRECKENRIDGE","","Approval"
"12/01/2017","THIAMINE HYDROCHLORIDEANDA  #206106","ORIG-1","THIAMINE HYDROCHLORIDE","SAGENT PHARMS INC","","Approval"
"12/01/2017","IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDEANDA  #209235","ORIG-1","IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE","AUROBINDO PHARMA LTD","","Approval"
"12/01/2017","OGIVRIBLA   #761074","ORIG-1","TRASTUZUMAB-DKST","MYLAN GMBH","","Approval"
"12/04/2017","FLAGYL I.V. RTU IN PLASTIC CONTAINERNDA   #018657","SUPPL-36","METRONIDAZOLE","BAXTER HLTHCARE","Labeling","Approval"
"12/04/2017","NUVARINGNDA   #021187","SUPPL-34","ETHINYL ESTRADIOL; ETONOGESTREL","ORGANON SUB MERCK","Labeling","Approval"
"12/04/2017","PIPERACILLIN AND TAZOBACTAMANDA  #065446","SUPPL-3","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","HOSPIRA INC","Labeling","Approval"
"12/04/2017","PIPERACILLIN AND TAZOBACTAMANDA  #065446","SUPPL-7","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","HOSPIRA INC","Labeling","Approval"
"12/04/2017","PIPERACILLIN AND TAZOBACTAMANDA  #065446","SUPPL-10","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","HOSPIRA INC","Labeling","Approval"
"12/04/2017","PIPERACILLIN AND TAZOBACTAMANDA  #065446","SUPPL-11","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","HOSPIRA INC","Labeling","Approval"
"12/04/2017","PIPERACILLIN AND TAZOBACTAMANDA  #065446","SUPPL-13","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","HOSPIRA INC","Labeling","Approval"
"12/04/2017","PIPERACILLIN AND TAZOBACTAMANDA  #065446","SUPPL-14","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","HOSPIRA INC","Labeling","Approval"
"12/04/2017","ARIPIPRAZOLEANDA  #205363","ORIG-1","ARIPIPRAZOLE","PRINSTON INC","","Approval"
"12/04/2017","RANOLAZINEANDA  #209081","ORIG-1","RANOLAZINE","AUROBINDO PHARMA LTD","","Tentative Approval"
"12/05/2017","HALDOLNDA   #015923","SUPPL-92","HALOPERIDOL LACTATE","JANSSEN PHARMS","Labeling","Approval"
"12/05/2017","HALDOLNDA   #018701","SUPPL-70","HALOPERIDOL DECANOATE","JANSSEN PHARMS","Labeling","Approval"
"12/05/2017","LEVO-TNDA   #021342","SUPPL-23","LEVOTHYROXINE SODIUM","CEDIPROF INC","Labeling","Approval"
"12/05/2017","OLOPATADINE HYDROCHLORIDEANDA  #090918","ORIG-1","OLOPATADINE HYDROCHLORIDE","APOTEX INC","","Approval"
"12/05/2017","AVASTINBLA   #125085","SUPPL-319","BEVACIZUMAB","GENENTECH","","Approval"
"12/05/2017","OLOPATADINE HYDROCHLORIDEANDA  #204723","ORIG-1","OLOPATADINE HYDROCHLORIDE","AKORN","","Approval"
"12/05/2017","OLOPATADINE HYDROCHLORIDEANDA  #206087","ORIG-1","OLOPATADINE HYDROCHLORIDE","CIPLA","","Approval"
"12/05/2017","LONHALA MAGNAIR KITNDA   #208437","ORIG-1","GLYCOPYRROLATE","SUNOVION RESP","Type 3 - New Dosage Form and Type 4 - New Combination","Approval"
"12/05/2017","GANZYK-RTUNDA   #209347","SUPPL-2","GANCICLOVIR","EXELA PHARMA","Manufacturing (CMC)","Approval"
"12/05/2017","OZEMPICNDA   #209637","ORIG-1","SEMAGLUTIDE","NOVO","Type 1 - New Molecular Entity","Approval"
"12/06/2017","LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINERNDA   #016679","SUPPL-108","CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","BAXTER HLTHCARE","Labeling","Approval"
"12/06/2017","POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINERNDA   #019367","SUPPL-30","CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","BAXTER HLTHCARE","Labeling","Approval"
"12/06/2017","POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINERNDA   #019367","SUPPL-30","CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","BAXTER HLTHCARE","Labeling","Approval"
"12/06/2017","POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINERNDA   #019367","SUPPL-30","CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","BAXTER HLTHCARE","Labeling","Approval"
"12/06/2017","POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINERNDA   #019367","SUPPL-30","CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","BAXTER HLTHCARE","Labeling","Approval"
"12/06/2017","POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINERNDA   #019367","SUPPL-30","CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","BAXTER HLTHCARE","Labeling","Approval"
"12/06/2017","POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINERNDA   #019367","SUPPL-30","CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","BAXTER HLTHCARE","Labeling","Approval"
"12/06/2017","CAVERJECTNDA   #020379","SUPPL-31","ALPROSTADIL","PFIZER","Labeling","Approval"
"12/06/2017","CAVERJECTNDA   #020379","SUPPL-32","ALPROSTADIL","PFIZER","Labeling","Approval"
"12/06/2017","CAVERJECTNDA   #020379","SUPPL-34","ALPROSTADIL","PFIZER","Labeling","Approval"
"12/06/2017","PROTONIXNDA   #020987","SUPPL-52","PANTOPRAZOLE SODIUM","WYETH PHARMS","Labeling","Approval"
"12/06/2017","PROTONIX IVNDA   #020988","SUPPL-58","PANTOPRAZOLE SODIUM","WYETH PHARMS","Labeling","Approval"
"12/06/2017","PROTONIXNDA   #022020","SUPPL-14","PANTOPRAZOLE SODIUM","WYETH PHARMS","Labeling","Approval"
"12/06/2017","JAKAFINDA   #202192","SUPPL-15","RUXOLITINIB PHOSPHATE","INCYTE CORP","Labeling","Approval"
"12/06/2017","LINEZOLIDANDA  #205154","ORIG-1","LINEZOLID","MYLAN LABS LTD","","Approval"
"12/06/2017","GEMCITABINE HYDROCHLORIDEANDA  #205242","ORIG-1","GEMCITABINE HYDROCHLORIDE","MYLAN LABS LTD","","Approval"
"12/06/2017","MAGNESIUM SULFATE IN PLASTIC CONTAINERANDA  #207350","ORIG-1","MAGNESIUM SULFATE","HQ SPCLT PHARMA","","Approval"
"12/06/2017","DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDEANDA  #208518","ORIG-1","DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE","PAR PHARM INC","","Approval"
"12/06/2017","CLOZAPINEANDA  #209480","ORIG-1","CLOZAPINE","ZYDUS PHARMS","","Approval"
"12/06/2017","CLOFARABINEANDA  #209775","ORIG-1","CLOFARABINE","MSN","","Approval"
"12/07/2017","BICILLIN C-RNDA   #050138","SUPPL-238","PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE","KING PHARMS LLC","Labeling","Approval"
"12/07/2017","BICILLIN C-R 900/300NDA   #050138","SUPPL-238","PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE","KING PHARMS LLC","Labeling","Approval"
"12/07/2017","BICILLIN L-ANDA   #050141","SUPPL-235","PENICILLIN G BENZATHINE","KING PHARMS LLC","Labeling","Approval"
"12/07/2017","BENDAMUSTINE HYDROCHLORIDEANDA  #205752","ORIG-1","BENDAMUSTINE HYDROCHLORIDE","SPECTRUM PHARMS","","Tentative Approval"
"12/07/2017","PREGABALINANDA  #207883","ORIG-1","PREGABALIN","PRINSTON PHARMA INC","","Tentative Approval"
"12/08/2017","ZYRTEC ALLERGYNDA   #019835","SUPPL-39","CETIRIZINE HYDROCHLORIDE","J AND J CONSUMER INC","Manufacturing (CMC)","Approval"
"12/08/2017","ZYRTEC HIVES RELIEFNDA   #019835","SUPPL-39","CETIRIZINE HYDROCHLORIDE","J AND J CONSUMER INC","Manufacturing (CMC)","Approval"
"12/08/2017","ZOLOFTNDA   #019839","SUPPL-91","SERTRALINE HYDROCHLORIDE","UPJOHN","Labeling","Approval"
"12/08/2017","ZOLOFTNDA   #019839","SUPPL-93","SERTRALINE HYDROCHLORIDE","UPJOHN","Labeling","Approval"
"12/08/2017","ZOLOFTNDA   #020990","SUPPL-49","SERTRALINE HYDROCHLORIDE","UPJOHN","Labeling","Approval"
"12/08/2017","ZOLOFTNDA   #020990","SUPPL-50","SERTRALINE HYDROCHLORIDE","UPJOHN","Labeling","Approval"
"12/08/2017","TRUVADANDA   #021752","SUPPL-54","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","REMS","Approval"
"12/08/2017","TIROSINTNDA   #021924","SUPPL-13","LEVOTHYROXINE SODIUM","INSTITUT BIOCHIMIQUE","Labeling","Approval"
"12/08/2017","PRANDIMETNDA   #022386","SUPPL-16","METFORMIN HYDROCHLORIDE; REPAGLINIDE","NOVO NORDISK INC","Labeling","Approval"
"12/08/2017","EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #090894","SUPPL-2","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","TEVA PHARMS USA","REMS","Approval"
"12/08/2017","MELPHALAN HYDROCHLORIDEANDA  #203655","ORIG-1","MELPHALAN HYDROCHLORIDE","DR REDDYS LABS LTD","","Approval"
"12/08/2017","LEVOFLOXACINANDA  #204899","ORIG-1","LEVOFLOXACIN","MYLAN LABS LTD","","Approval"
"12/08/2017","HYDROCORTISONE BUTYRATEANDA  #205134","ORIG-1","HYDROCORTISONE BUTYRATE","ACTAVIS MID ATLANTIC","","Approval"
"12/08/2017","BUSULFANANDA  #205139","ORIG-1","BUSULFAN","ACTAVIS LLC","","Approval"
"12/08/2017","OMIDRIANDA   #205388","SUPPL-6","KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE","OMEROS","Efficacy","Approval"
"12/08/2017","GANCICLOVIR SODIUMANDA  #207645","ORIG-1","GANCICLOVIR SODIUM","PHARMASCIENCE INC","","Approval"
"12/08/2017","DARIFENACIN HYDROBROMIDEANDA  #207681","ORIG-1","DARIFENACIN HYDROBROMIDE","ALEMBIC PHARMS LTD","","Approval"
"12/08/2017","TIAGABINE HYDROCHLORIDEANDA  #208181","ORIG-1","TIAGABINE HYDROCHLORIDE","AMNEAL PHARMS CO","","Approval"
"12/08/2017","ZOLEDRONIC ACIDANDA  #209125","ORIG-1","ZOLEDRONIC ACID","EUGIA PHARMA","","Approval"
"12/08/2017","SINUVANDA   #209310","ORIG-1","MOMETASONE FUROATE","INTERSECT ENT INC","Type 3 - New Dosage Form","Approval"
"12/08/2017","SODIUM NITROPRUSSIDEANDA  #209352","ORIG-1","SODIUM NITROPRUSSIDE","MICRO LABS","","Approval"
"12/08/2017","DEFERASIROXANDA  #209426","ORIG-1","DEFERASIROX","TORRENT PHARMS LTD","","Tentative Approval"
"12/09/2017","NEULASTABLA   #125031","SUPPL-189","PEGFILGRASTIM","AMGEN","","Approval"
"12/09/2017","NEULASTABLA   #125031","SUPPL-191","PEGFILGRASTIM","AMGEN","","Approval"
"12/11/2017","NICORETTENDA   #018612","SUPPL-79","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling","Approval"
"12/11/2017","NICORETTE (MINT)NDA   #018612","SUPPL-79","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling","Approval"
"12/11/2017","NICORETTENDA   #020066","SUPPL-60","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling","Approval"
"12/11/2017","NICORETTE (MINT)NDA   #020066","SUPPL-60","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling","Approval"
"12/11/2017","MYALEPTBLA   #125390","SUPPL-12","METRELEPTIN","AEGERION","","Approval"
"12/11/2017","ARIPIPRAZOLEANDA  #202547","ORIG-1","ARIPIPRAZOLE","ORBION PHARMS","","Approval"
"12/11/2017","TRIAMCINOLONE ACETONIDEANDA  #207550","ORIG-1","TRIAMCINOLONE ACETONIDE","AMNEAL","","Approval"
"12/11/2017","XEPINDA   #208945","ORIG-1","OZENOXACIN","FERRER INTERNACIONAL","Type 1 - New Molecular Entity","Approval"
"12/11/2017","ADMELOGBLA   #209196","ORIG-1","INSULIN LISPRO","SANOFI-AVENTIS US","","Approval"
"12/11/2017","ADMELOG SOLOSTARBLA   #209196","ORIG-1","INSULIN LISPRO","SANOFI-AVENTIS US","","Approval"
"12/11/2017","MAVYRETNDA   #209394","SUPPL-3","GLECAPREVIR; PIBRENTASVIR","ABBVIE INC","Labeling","Approval"
"12/12/2017","OPTIRAY 240NDA   #020923","SUPPL-21","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"12/12/2017","OPTIRAY 300NDA   #020923","SUPPL-21","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"12/12/2017","OPTIRAY 320NDA   #020923","SUPPL-21","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"12/12/2017","OPTIRAY 350NDA   #020923","SUPPL-21","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"12/12/2017","TANZEUMBLA   #125431","SUPPL-21","ALBIGLUTIDE","GLAXOSMITHKLINE LLC","","Approval"
"12/12/2017","TRULICITYBLA   #125469","SUPPL-21","DULAGLUTIDE","ELI LILLY AND CO","","Approval"
"12/12/2017","NUCALABLA   #125526","SUPPL-4","MEPOLIZUMAB","GLAXOSMITHKLINE LLC","","Approval"
"12/12/2017","PRAMIPEXOLE DIHYDROCHLORIDEANDA  #202891","ORIG-1","PRAMIPEXOLE DIHYDROCHLORIDE","ZYDUS PHARMS","","Approval"
"12/12/2017","NITROFURANTOINANDA  #205005","ORIG-1","NITROFURANTOIN, MACROCRYSTALLINE","ZYDUS PHARMS","","Approval"
"12/12/2017","TYDEMYANDA  #205948","ORIG-1","DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM","LUPIN LTD","","Approval"
"12/12/2017","TOLTERODINE TARTRATEANDA  #206419","ORIG-1","TOLTERODINE TARTRATE","HETERO LABS LTD III","","Approval"
"12/12/2017","VALGANCICLOVIR HYDROCHLORIDEANDA  #206876","ORIG-1","VALGANCICLOVIR HYDROCHLORIDE","DR REDDYS","","Approval"
"12/12/2017","XULTOPHY 100/3.6BLA   #208583","SUPPL-1","INSULIN DEGLUDEC; LIRAGLUTIDE","NOVO","","Approval"
"12/12/2017","METRONIDAZOLEANDA  #209794","ORIG-1","METRONIDAZOLE","CADILA PHARMS LTD","","Approval"
"12/13/2017","DILTIAZEM HYDROCHLORIDEANDA  #074941","SUPPL-9","DILTIAZEM HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"12/13/2017","DILTIAZEM HYDROCHLORIDEANDA  #075853","SUPPL-9","DILTIAZEM HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"12/13/2017","AMANTADINE HYDROCHLORIDEANDA  #076186","SUPPL-22","AMANTADINE HYDROCHLORIDE","UPSHER SMITH LABS","Manufacturing (CMC)","Approval"
"12/13/2017","CAMPATHBLA   #103948","SUPPL-5159","ALEMTUZUMAB","GENZYME","","Approval"
"12/13/2017","LEMTRADABLA   #103948","SUPPL-5159","ALEMTUZUMAB","GENZYME","","Approval"
"12/13/2017","YERVOYBLA   #125377","SUPPL-91","IPILIMUMAB","BRISTOL MYERS SQUIBB","","Approval"
"12/13/2017","JARDIANCENDA   #204629","SUPPL-16","EMPAGLIFLOZIN","BOEHRINGER INGELHEIM","Labeling","Approval"
"12/13/2017","OFEVNDA   #205832","SUPPL-7","NINTEDANIB ESYLATE","BOEHRINGER INGELHEIM","Labeling","Approval"
"12/13/2017","GLYXAMBINDA   #206073","SUPPL-12","EMPAGLIFLOZIN; LINAGLIPTIN","BOEHRINGER INGELHEIM","Labeling","Approval"
"12/13/2017","SYNJARDYNDA   #206111","SUPPL-15","EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","BOEHRINGER INGELHEIM","Labeling","Approval"
"12/13/2017","DARUNAVIRANDA  #206288","ORIG-1","DARUNAVIR","CIPLA LTD","","Tentative Approval"
"12/13/2017","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207000","ORIG-1","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","SPECGX LLC","","Approval"
"12/13/2017","SYNJARDY XRNDA   #208658","SUPPL-4","EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","BOEHRINGER INGELHEIM","Labeling","Approval"
"12/13/2017","IXIFIBLA   #761072","ORIG-1","INFLIXIMAB-QBTX","PFIZER INC","","Approval"
"12/14/2017","IMITREXNDA   #020080","SUPPL-50","SUMATRIPTAN SUCCINATE","GLAXOSMITHKLINE","Labeling","Approval"
"12/14/2017","IMITREX STATDOSENDA   #020080","SUPPL-50","SUMATRIPTAN SUCCINATE","GLAXOSMITHKLINE","Labeling","Approval"
"12/14/2017","IMITREXNDA   #020132","SUPPL-29","SUMATRIPTAN SUCCINATE","GLAXOSMITHKLINE","Labeling","Approval"
"12/14/2017","IMITREXNDA   #020626","SUPPL-27","SUMATRIPTAN","GLAXOSMITHKLINE","Labeling","Approval"
"12/14/2017","VIAGRANDA   #020895","SUPPL-48","SILDENAFIL CITRATE","UPJOHN","Labeling","Approval"
"12/14/2017","BENAZEPRIL HYDROCHLORIDEANDA  #076344","SUPPL-17","BENAZEPRIL HYDROCHLORIDE","SUN PHARM INDS LTD","Labeling","Approval"
"12/14/2017","BENAZEPRIL HYDROCHLORIDEANDA  #077128","SUPPL-14","BENAZEPRIL HYDROCHLORIDE","ANNORA PHARMA","Labeling","Approval"
"12/14/2017","GALANTAMINE HYDROBROMIDEANDA  #077587","SUPPL-2","GALANTAMINE HYDROBROMIDE","HERITAGE PHARMA","Labeling","Approval"
"12/14/2017","GALANTAMINE HYDROBROMIDEANDA  #077590","SUPPL-11","GALANTAMINE HYDROBROMIDE","MYLAN","Labeling","Approval"
"12/14/2017","GALANTAMINE HYDROBROMIDEANDA  #077603","SUPPL-2","GALANTAMINE HYDROBROMIDE","MYLAN","Labeling","Approval"
"12/14/2017","GALANTAMINE HYDROBROMIDEANDA  #077781","SUPPL-5","GALANTAMINE HYDROBROMIDE","APOTEX INC","Labeling","Approval"
"12/14/2017","GALANTAMINE HYDROBROMIDEANDA  #078898","SUPPL-7","GALANTAMINE HYDROBROMIDE","ZYDUS PHARMS USA INC","Labeling","Approval"
"12/14/2017","GALANTAMINE HYDROBROMIDEANDA  #079028","SUPPL-10","GALANTAMINE HYDROBROMIDE","WATSON LABS","Labeling","Approval"
"12/14/2017","GALANTAMINE HYDROBROMIDEANDA  #090957","SUPPL-11","GALANTAMINE HYDROBROMIDE","AUROBINDO PHARMA LTD","Labeling","Approval"
"12/14/2017","HUMIRABLA   #125057","SUPPL-403","ADALIMUMAB","ABBVIE INC","","Approval"
"12/14/2017","ZOLEDRONIC ACIDANDA  #200918","SUPPL-1","ZOLEDRONIC ACID","AKORN","Labeling","Approval"
"12/14/2017","BUPROPION HYDROCHLORIDEANDA  #202304","SUPPL-4","BUPROPION HYDROCHLORIDE","PRINSTON INC","Labeling","Approval"
"12/14/2017","BUPROPION HYDROCHLORIDEANDA  #202304","SUPPL-9","BUPROPION HYDROCHLORIDE","PRINSTON INC","Labeling","Approval"
"12/14/2017","BUPROPION HYDROCHLORIDEANDA  #202304","SUPPL-10","BUPROPION HYDROCHLORIDE","PRINSTON INC","Labeling","Approval"
"12/14/2017","XELJANZNDA   #203214","SUPPL-17","TOFACITINIB CITRATE","PF PRISM CV","Efficacy","Approval"
"12/14/2017","LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOLANDA  #205131","ORIG-1","ETHINYL ESTRADIOL; LEVONORGESTREL","XIROMED","","Approval"
"12/14/2017","CAFFEINE CITRATEANDA  #207400","ORIG-1","CAFFEINE CITRATE","MICRO LABS","","Approval"
"12/14/2017","DROPERIDOLANDA  #208197","ORIG-1","DROPERIDOL","EUROHLTH INTL SARL","","Approval"
"12/14/2017","XELJANZ XRNDA   #208246","SUPPL-3","TOFACITINIB CITRATE","PFIZER","Efficacy","Approval"
"12/14/2017","ALTAFLUOR BENOXNDA   #208582","ORIG-1","BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM","ALTAIRE PHARMS INC","Type 4 - New Combination","Approval"
"12/14/2017","ESKATANDA   #209305","ORIG-1","HYDROGEN PEROXIDE","ACLARIS","Type 5 - New Formulation or New Manufacturer","Approval"
"12/14/2017","GOPRELTONDA   #209963","ORIG-1","COCAINE HYDROCHLORIDE","GENUS LIFESCIENCES","Type 5 - New Formulation or New Manufacturer","Approval"
"12/15/2017","NEVANACNDA   #021862","SUPPL-13","NEPAFENAC","NOVARTIS","Labeling","Approval"
"12/15/2017","TREANDANDA   #022249","SUPPL-23","BENDAMUSTINE HYDROCHLORIDE","CEPHALON","Labeling","Approval"
"12/15/2017","GILENYANDA   #022527","SUPPL-22","FINGOLIMOD HYDROCHLORIDE","NOVARTIS","Labeling","Approval"
"12/15/2017","DEXAMETHASONEANDA  #040700","SUPPL-2","DEXAMETHASONE","BAUSCH","Manufacturing (CMC)","Approval"
"12/15/2017","EFAVIRENZANDA  #078064","ORIG-1","EFAVIRENZ","AUROBINDO PHARMA LTD","","Approval"
"12/15/2017","TECFIDERANDA   #204063","SUPPL-20","DIMETHYL FUMARATE","BIOGEN INC","Labeling","Approval"
"12/15/2017","CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDEANDA  #206218","ORIG-1","BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","TARO PHARMS","","Approval"
"12/15/2017","LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #206473","SUPPL-1","LINEZOLID","HOSPIRA INC","Labeling","Approval"
"12/15/2017","AZELASTINE HYDROCHLORIDEANDA  #208199","ORIG-1","AZELASTINE HYDROCHLORIDE","AMNEAL","","Approval"
"12/17/2017","XIIDRANDA   #208073","SUPPL-2","LIFITEGRAST","NOVARTIS","Labeling","Approval"
"12/17/2017","MEDICAL AIR, USPNDA   #211270","ORIG-1","MEDICAL AIR","LINDE GAS PUERTO RICO INC","Medical Gas","Approval"
"12/18/2017","CLOMIDNDA   #016131","SUPPL-28","CLOMIPHENE CITRATE","SANOFI AVENTIS US","Labeling","Approval"
"12/18/2017","DROXIANDA   #016295","SUPPL-49","HYDROXYUREA","BRISTOL MYERS SQUIBB","Labeling","Approval"
"12/18/2017","DROXIANDA   #016295","SUPPL-50","HYDROXYUREA","BRISTOL MYERS SQUIBB","Labeling","Approval"
"12/18/2017","HYDREANDA   #016295","SUPPL-49","HYDROXYUREA","BRISTOL MYERS SQUIBB","Labeling","Approval"
"12/18/2017","HYDREANDA   #016295","SUPPL-50","HYDROXYUREA","BRISTOL MYERS SQUIBB","Labeling","Approval"
"12/18/2017","XIFAXANNDA   #021361","SUPPL-23","RIFAXIMIN","SALIX PHARMS","Labeling","Approval"
"12/18/2017","MAXITROLNDA   #050023","SUPPL-36","DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","NOVARTIS","Labeling","Approval"
"12/18/2017","MAXITROLNDA   #050065","SUPPL-64","DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","NOVARTIS","Labeling","Approval"
"12/18/2017","CELLCEPTNDA   #050722","SUPPL-37","MYCOPHENOLATE MOFETIL","ROCHE PALO","Labeling","Approval"
"12/18/2017","CELLCEPTNDA   #050723","SUPPL-37","MYCOPHENOLATE MOFETIL","ROCHE PALO","Labeling","Approval"
"12/18/2017","CELLCEPTNDA   #050758","SUPPL-34","MYCOPHENOLATE MOFETIL HYDROCHLORIDE","ROCHE PALO","Labeling","Approval"
"12/18/2017","CELLCEPTNDA   #050759","SUPPL-42","MYCOPHENOLATE MOFETIL","ROCHE PALO","Labeling","Approval"
"12/18/2017","VANCOCIN HYDROCHLORIDEANDA  #060180","SUPPL-48","VANCOMYCIN HYDROCHLORIDE","ANI PHARMS","Labeling","Approval"
"12/18/2017","HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206245","SUPPL-1","ACETAMINOPHEN; HYDROCODONE BITARTRATE","NOVEL LABS INC","Labeling","Approval"
"12/18/2017","HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206245","SUPPL-3","ACETAMINOPHEN; HYDROCODONE BITARTRATE","NOVEL LABS INC","Manufacturing (CMC)","Approval"
"12/18/2017","MESNAANDA  #206992","ORIG-1","MESNA","GLAND","","Approval"
"12/18/2017","NEXIUM 24HRNDA   #207920","SUPPL-2","ESOMEPRAZOLE MAGNESIUM","ASTRAZENECA LP","Labeling","Approval"
"12/18/2017","RHOPRESSANDA   #208254","ORIG-1","NETARSUDIL MESYLATE","AERIE PHARMS INC","Type 1 - New Molecular Entity","Approval"
"12/18/2017","TETRABENAZINEANDA  #208826","ORIG-1","TETRABENAZINE","BIONPHARMA INC","","Approval"
"12/18/2017","BUSULFANANDA  #209580","ORIG-1","BUSULFAN","AMNEAL","","Approval"
"12/18/2017","SODIUM NITROPRUSSIDEANDA  #209832","ORIG-1","SODIUM NITROPRUSSIDE","AMPHASTAR PHARMS INC","","Approval"
"12/19/2017","ZERITNDA   #020412","SUPPL-40","STAVUDINE","BRISTOL MYERS SQUIBB","Labeling","Approval"
"12/19/2017","ZERITNDA   #020413","SUPPL-32","STAVUDINE","BRISTOL-MYERS SQUIBB","Labeling","Approval"
"12/19/2017","EFFEXOR XRNDA   #020699","SUPPL-110","VENLAFAXINE HYDROCHLORIDE","UPJOHN","Labeling","Approval"
"12/19/2017","EFFEXOR XRNDA   #020699","SUPPL-111","VENLAFAXINE HYDROCHLORIDE","UPJOHN","Labeling","Approval"
"12/19/2017","CYMBALTANDA   #021427","SUPPL-50","DULOXETINE HYDROCHLORIDE","LILLY","Labeling","Approval"
"12/19/2017","PRISTIQNDA   #021992","SUPPL-46","DESVENLAFAXINE SUCCINATE","PF PRISM CV","Labeling","Approval"
"12/19/2017","VENLAFAXINE HYDROCHLORIDENDA   #022104","SUPPL-16","VENLAFAXINE HYDROCHLORIDE","OSMOTICA PHARM","Labeling","Approval"
"12/19/2017","SAVELLANDA   #022256","SUPPL-23","MILNACIPRAN HYDROCHLORIDE","ALLERGAN","Labeling","Approval"
"12/19/2017","CASPORYN HCNDA   #060613","SUPPL-13","HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","CASPER PHARMA LLC","Labeling","Approval"
"12/19/2017","AUBAGIONDA   #202992","SUPPL-4","TERIFLUNOMIDE","SANOFI AVENTIS US","Labeling","Approval"
"12/19/2017","BOSULIFNDA   #203341","SUPPL-9","BOSUTINIB MONOHYDRATE","PF PRISM CV","Efficacy","Approval"
"12/19/2017","DESVENLAFAXINENDA   #204150","SUPPL-7","DESVENLAFAXINE","ALEMBIC PHARMS LTD","Labeling","Approval"
"12/19/2017","FETZIMANDA   #204168","SUPPL-5","LEVOMILNACIPRAN HYDROCHLORIDE","ALLERGAN","Labeling","Approval"
"12/19/2017","BORTEZOMIBANDA  #204332","ORIG-1","BORTEZOMIB","ACTAVIS LLC","","Tentative Approval"
"12/19/2017","KHEDEZLANDA   #204683","SUPPL-5","DESVENLAFAXINE","OSMOTICA PHARM CORP","Labeling","Approval"
"12/19/2017","DESVENLAFAXINENDA   #205583","SUPPL-6","DESVENLAFAXINE FUMARATE","SUN PHARMA GLOBAL","Labeling","Approval"
"12/19/2017","AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEANDA  #206180","ORIG-1","AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN","AUROBINDO PHARMA LTD","","Approval"
"12/19/2017","FENOFIBRATEANDA  #207803","ORIG-1","FENOFIBRATE","AUSTARPHARMA","","Approval"
"12/19/2017","CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDENDA   #208083","SUPPL-1","CLINDAMYCIN PHOSPHATE","BAXTER HLTHCARE CORP","Labeling","Approval"
"12/19/2017","CABOMETYXNDA   #208692","SUPPL-2","CABOZANTINIB S-MALATE","EXELIXIS INC","Efficacy","Approval"
"12/19/2017","PREXXARTANNDA   #209139","ORIG-1","VALSARTAN","CARMEL BIOSCIENCES","Type 3 - New Dosage Form","Approval"
"12/19/2017","STEGLATRONDA   #209803","ORIG-1","ERTUGLIFLOZIN","MERCK SHARP DOHME","Type 1 - New Molecular Entity","Approval"
"12/19/2017","STEGLUJANNDA   #209805","ORIG-1","ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Type 4 - New Combination","Approval"
"12/19/2017","SEGLUROMETNDA   #209806","ORIG-1","ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE","MERCK SHARP DOHME","Type 4 - New Combination","Approval"
"12/19/2017","NIFEDIPINEANDA  #210012","ORIG-1","NIFEDIPINE","ZYDUS PHARMS","","Approval"
"12/20/2017","ALBENZANDA   #020666","SUPPL-10","ALBENDAZOLE","IMPAX LABS INC","Labeling","Approval"
"12/20/2017","PROTONIXNDA   #020987","SUPPL-51","PANTOPRAZOLE SODIUM","WYETH PHARMS","Labeling","Approval"
"12/20/2017","PROTONIX IVNDA   #020988","SUPPL-55","PANTOPRAZOLE SODIUM","WYETH PHARMS","Labeling","Approval"
"12/20/2017","ADVAIR DISKUS 100/50NDA   #021077","SUPPL-56","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Efficacy","Approval"
"12/20/2017","ADVAIR DISKUS 100/50NDA   #021077","SUPPL-57","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Efficacy","Approval"
"12/20/2017","ADVAIR DISKUS 250/50NDA   #021077","SUPPL-56","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Efficacy","Approval"
"12/20/2017","ADVAIR DISKUS 250/50NDA   #021077","SUPPL-57","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Efficacy","Approval"
"12/20/2017","ADVAIR DISKUS 500/50NDA   #021077","SUPPL-56","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Efficacy","Approval"
"12/20/2017","ADVAIR DISKUS 500/50NDA   #021077","SUPPL-57","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Efficacy","Approval"
"12/20/2017","ADVAIR HFANDA   #021254","SUPPL-27","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Labeling","Approval"
"12/20/2017","SYMBICORTNDA   #021929","SUPPL-42","BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE","ASTRAZENECA","Efficacy","Approval"
"12/20/2017","PROTONIXNDA   #022020","SUPPL-13","PANTOPRAZOLE SODIUM","WYETH PHARMS","Labeling","Approval"
"12/20/2017","INVEGA SUSTENNANDA   #022264","SUPPL-15","PALIPERIDONE PALMITATE","JANSSEN PHARMS","Efficacy","Approval"
"12/20/2017","DULERANDA   #022518","SUPPL-22","FORMOTEROL FUMARATE; MOMETASONE FUROATE","ORGANON","Efficacy","Approval"
"12/20/2017","DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATEANDA  #085372","SUPPL-14","ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE","LANNETT","Manufacturing (CMC)","Approval"
"12/20/2017","PERJETABLA   #125409","SUPPL-113","PERTUZUMAB","GENENTECH","","Approval"
"12/20/2017","PERJETABLA   #125409","SUPPL-118","PERTUZUMAB","GENENTECH","","Approval"
"12/20/2017","TANZEUMBLA   #125431","SUPPL-20","ALBIGLUTIDE","GLAXOSMITHKLINE LLC","","Approval"
"12/20/2017","OPDIVOBLA   #125554","SUPPL-55","NIVOLUMAB","BRISTOL MYERS SQUIBB","","Approval"
"12/20/2017","ICLUSIGNDA   #203469","SUPPL-27","PONATINIB HYDROCHLORIDE","TAKEDA PHARMS USA","Labeling","Approval"
"12/20/2017","ICLUSIGNDA   #203469","SUPPL-28","PONATINIB HYDROCHLORIDE","TAKEDA PHARMS USA","Labeling","Approval"
"12/20/2017","BREO ELLIPTANDA   #204275","SUPPL-15","FLUTICASONE FUROATE; VILANTEROL TRIFENATATE","GLAXO GRP LTD","Labeling","Approval"
"12/20/2017","IMBRUVICANDA   #205552","SUPPL-20","IBRUTINIB","PHARMACYCLICS INC","Efficacy","Approval"
"12/20/2017","MACRILENNDA   #205598","ORIG-1","MACIMORELIN ACETATE","NOVO","Type 1 - New Molecular Entity","Approval"
"12/20/2017","UPTRAVINDA   #207947","SUPPL-5","SELEXIPAG","ACTELION","Labeling","Approval"
"12/20/2017","VENCLEXTANDA   #208573","SUPPL-3","VENETOCLAX","ABBVIE INC","Efficacy","Approval"
"12/20/2017","AIRDUO DIGIHALERNDA   #208799","SUPPL-2","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","TEVA PHARM","Labeling","Approval"
"12/20/2017","AIRDUO RESPICLICKNDA   #208799","SUPPL-2","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","TEVA PHARM","Labeling","Approval"
"12/21/2017","SUDAFED 24 HOURNDA   #020021","SUPPL-11","PSEUDOEPHEDRINE HYDROCHLORIDE","J AND J CONSUMER INC","Labeling","Approval"
"12/21/2017","ACTOSNDA   #021073","SUPPL-49","PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Labeling","Approval"
"12/21/2017","ACTOPLUS METNDA   #021842","SUPPL-22","METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Labeling","Approval"
"12/21/2017","DUETACTNDA   #021925","SUPPL-17","GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Labeling","Approval"
"12/21/2017","ACTOPLUS MET XRNDA   #022024","SUPPL-14","METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Labeling","Approval"
"12/21/2017","OSENINDA   #022426","SUPPL-10","ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Labeling","Approval"
"12/21/2017","VARITHENANDA   #205098","SUPPL-26","POLIDOCANOL","PROVENSIS","Labeling","Approval"
"12/21/2017","ZYKADIANDA   #205755","SUPPL-10","CERITINIB","NOVARTIS","Efficacy","Approval"
"12/21/2017","IBUPROFENANDA  #206999","ORIG-1","IBUPROFEN","ASCENT PHARMS INC","","Approval"
"12/21/2017","BIVALIRUDIN IN 0.9% SODIUM CHLORIDENDA   #208374","ORIG-1","BIVALIRUDIN","BAXTER HLTHCARE CORP","Type 5 - New Formulation or New Manufacturer","Approval"
"12/21/2017","METHYLNALTREXONE BROMIDEANDA  #208594","ORIG-1","METHYLNALTREXONE BROMIDE","MYLAN PHARMS INC","","Tentative Approval"
"12/21/2017","SIKLOSNDA   #208843","ORIG-1","HYDROXYUREA","ADDMEDICA SAS","Type 3 - New Dosage Form","Approval"
"12/21/2017","OXYBUTYNIN CHLORIDEANDA  #209025","ORIG-1","OXYBUTYNIN CHLORIDE","APPCO","","Approval"
"12/21/2017","EZETIMIBEANDA  #209234","ORIG-1","EZETIMIBE","ALKEM LABS LTD","","Approval"
"12/21/2017","GIAPREZANDA   #209360","ORIG-1","ANGIOTENSIN II ACETATE","LA JOLLA PHARMA","Type 1 - New Molecular Entity","Approval"
"12/22/2017","XYLOCAINENDA   #006488","SUPPL-90","LIDOCAINE HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"12/22/2017","XYLOCAINENDA   #006488","SUPPL-95","LIDOCAINE HYDROCHLORIDE","FRESENIUS KABI USA","Manufacturing (CMC)","Approval"
"12/22/2017","XYLOCAINE W/ EPINEPHRINENDA   #006488","SUPPL-90","EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"12/22/2017","XYLOCAINE W/ EPINEPHRINENDA   #006488","SUPPL-95","EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","FRESENIUS KABI USA","Manufacturing (CMC)","Approval"
"12/22/2017","DRAXIMAGE DTPANDA   #018511","SUPPL-20","TECHNETIUM TC-99M PENTETATE KIT","JUBILANT","Manufacturing (CMC)","Approval"
"12/22/2017","BETAGANNDA   #019219","SUPPL-29","LEVOBUNOLOL HYDROCHLORIDE","ALLERGAN","Labeling","Approval"
"12/22/2017","CETROTIDENDA   #021197","SUPPL-18","CETRORELIX","EMD SERONO INC","Labeling","Approval"
"12/22/2017","CHLORAPREP ONE-STEP SEPPNDA   #021555","SUPPL-20","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","BECTON DICKINSON CO","Manufacturing (CMC)","Approval"
"12/22/2017","CHLORAPREP SINGLE SWABSTICKNDA   #021555","SUPPL-20","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","BECTON DICKINSON CO","Manufacturing (CMC)","Approval"
"12/22/2017","CHLORAPREP TRIPLE SWABSTICKNDA   #021555","SUPPL-20","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","BECTON DICKINSON CO","Manufacturing (CMC)","Approval"
"12/22/2017","NEXAVARNDA   #021923","SUPPL-18","SORAFENIB TOSYLATE","BAYER HLTHCARE","Efficacy","Approval"
"12/22/2017","TASIGNANDA   #022068","SUPPL-26","NILOTINIB HYDROCHLORIDE","NOVARTIS","Efficacy","Approval"
"12/22/2017","FERAHEMENDA   #022180","SUPPL-16","FERUMOXYTOL","COVIS","Labeling","Approval"
"12/22/2017","MITOSOLNDA   #022572","SUPPL-5","MITOMYCIN","MOBIUS THERAP","Labeling","Approval"
"12/22/2017","PROPOFOLANDA  #075102","SUPPL-38","PROPOFOL","SAGENT PHARMS INC","Labeling","Approval"
"12/22/2017","DILANTINANDA  #084349","SUPPL-81","PHENYTOIN SODIUM","UPJOHN","Labeling","Approval"
"12/22/2017","DILANTINANDA  #084349","SUPPL-82","PHENYTOIN SODIUM","UPJOHN","Labeling","Approval"
"12/22/2017","DILANTINANDA  #084349","SUPPL-84","PHENYTOIN SODIUM","UPJOHN","Labeling","Approval"
"12/22/2017","DILANTINANDA  #084427","SUPPL-38","PHENYTOIN","PHARMACIA","Labeling","Approval"
"12/22/2017","DILANTINANDA  #084427","SUPPL-39","PHENYTOIN","PHARMACIA","Labeling","Approval"
"12/22/2017","DILANTINANDA  #084427","SUPPL-41","PHENYTOIN","PHARMACIA","Labeling","Approval"
"12/22/2017","PROCYSBINDA   #203389","SUPPL-20","CYSTEAMINE BITARTRATE","HORIZON","Efficacy","Approval"
"12/22/2017","MELPHALAN HYDROCHLORIDEANDA  #203393","ORIG-1","MELPHALAN HYDROCHLORIDE","FRESENIUS KABI USA","","Approval"
"12/22/2017","LORAZEPAMANDA  #203572","ORIG-1","LORAZEPAM","AUROLIFE PHARMA LLC","","Approval"
"12/22/2017","ABACAVIR SULFATEANDA  #206725","ORIG-1","ABACAVIR SULFATE","MICRO LABS LTD","","Tentative Approval"
"12/22/2017","LUMIFYNDA   #208144","ORIG-1","BRIMONIDINE TARTRATE","BAUSCH AND LOMB INC","Type 5 - New Formulation or New Manufacturer","Approval"
"12/22/2017","CALCIUM GLUCONATENDA   #208418","SUPPL-1","CALCIUM GLUCONATE","FRESENIUS KABI USA","Labeling","Approval"
"12/22/2017","CALCIUM GLUCONATE IN SODIUM CHLORIDENDA   #208418","SUPPL-1","CALCIUM GLUCONATE","FRESENIUS KABI USA","Labeling","Approval"
"12/22/2017","TAZAROTENEANDA  #208662","ORIG-1","TAZAROTENE","COSETTE","","Approval"
"12/22/2017","EZETIMIBE AND SIMVASTATINANDA  #209222","ORIG-1","EZETIMIBE; SIMVASTATIN","ALKEM LABS LTD","","Approval"
"12/22/2017","CETIRIZINE HYDROCHLORIDE ALLERGYANDA  #209274","ORIG-1","CETIRIZINE HYDROCHLORIDE","GRANULES","","Approval"
"12/22/2017","OXYBUTYNIN CHLORIDEANDA  #209335","ORIG-1","OXYBUTYNIN CHLORIDE","ABHAI LLC","","Approval"
"12/22/2017","DROSPIRENONE AND ETHINYL ESTRADIOLANDA  #209423","ORIG-1","DROSPIRENONE; ETHINYL ESTRADIOL","JUBILANT CADISTA","","Approval"
"12/22/2017","METHOTREXATE SODIUMANDA  #210040","ORIG-1","METHOTREXATE SODIUM","AMNEAL PHARMS","","Approval"
"12/26/2017","DRAXIMAGE DTPANDA   #018511","SUPPL-28","TECHNETIUM TC-99M PENTETATE KIT","JUBILANT","Efficacy","Approval"
"12/26/2017","CHILDREN'S ADVILNDA   #020944","SUPPL-13","IBUPROFEN","GLAXOSMITHKLINE","Labeling","Approval"
"12/26/2017","JUNIOR STRENGTH ADVILNDA   #020944","SUPPL-13","IBUPROFEN","GLAXOSMITHKLINE","Labeling","Approval"
"12/26/2017","METFORMIN HYDROCHLORIDEANDA  #203832","ORIG-1","METFORMIN HYDROCHLORIDE","NOSTRUM LABS INC","","Approval"
"12/26/2017","DESIPRAMINE HYDROCHLORIDEANDA  #204963","ORIG-1","DESIPRAMINE HYDROCHLORIDE","NOVAST LABS","","Approval"
"12/26/2017","FONDAPARINUX SODIUMANDA  #206918","ORIG-1","FONDAPARINUX SODIUM","EUGIA PHARMA","","Approval"
"12/26/2017","CALCIPOTRIENEANDA  #207163","ORIG-1","CALCIPOTRIENE","NOVEL LABS INC","","Approval"
"12/26/2017","TRIAMCINOLONE ACETONIDEANDA  #207651","ORIG-1","TRIAMCINOLONE ACETONIDE","ALKEM LABS LTD","","Approval"
"12/26/2017","NYSTATIN AND TRIAMCINOLONE ACETONIDEANDA  #207730","ORIG-1","NYSTATIN; TRIAMCINOLONE ACETONIDE","CROWN LABS INC","","Approval"
"12/26/2017","NYSTATIN AND TRIAMCINOLONE ACETONIDEANDA  #207731","ORIG-1","NYSTATIN; TRIAMCINOLONE ACETONIDE","CROWN LABS INC","","Approval"
"12/26/2017","FLUOCINOLONE ACETONIDEANDA  #209596","ORIG-1","FLUOCINOLONE ACETONIDE","GLASSHOUSE PHARMS","","Approval"
"12/26/2017","FLUOROURACILANDA  #210124","ORIG-1","FLUOROURACIL","GLAND PHARMA LTD","","Approval"
"12/26/2017","NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #210369","ORIG-1","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","GLENMARK PHARMS LTD","","Approval"
"12/27/2017","DICYCLOMINE HYDROCHLORIDEANDA  #040169","SUPPL-4","DICYCLOMINE HYDROCHLORIDE","GENERICS","Labeling","Approval"
"12/27/2017","KETOROLAC TROMETHAMINEANDA  #077308","SUPPL-7","KETOROLAC TROMETHAMINE","APOTEX INC","Labeling","Approval"
"12/27/2017","GALANTAMINE HYDROBROMIDEANDA  #077604","SUPPL-2","GALANTAMINE HYDROBROMIDE","YABAO PHARM","Labeling","Approval"
"12/27/2017","LEVALBUTEROL HYDROCHLORIDEANDA  #077756","SUPPL-3","LEVALBUTEROL HYDROCHLORIDE","IMPAX LABS INC","Labeling","Approval"
"12/27/2017","IRINOTECAN HYDROCHLORIDEANDA  #078796","SUPPL-7","IRINOTECAN HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"12/27/2017","DOXYCYCLINE HYCLATEANDA  #090134","SUPPL-14","DOXYCYCLINE HYCLATE","ACTAVIS ELIZABETH","Labeling","Approval"
"12/27/2017","DOXYCYCLINE HYCLATEANDA  #090134","SUPPL-15","DOXYCYCLINE HYCLATE","ACTAVIS ELIZABETH","Labeling","Approval"
"12/27/2017","DOXYCYCLINE HYCLATEANDA  #090134","SUPPL-17","DOXYCYCLINE HYCLATE","ACTAVIS ELIZABETH","Labeling","Approval"
"12/27/2017","HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREXANDA  #091632","SUPPL-5","CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX","TRIS PHARMA INC","Manufacturing (CMC)","Approval"
"12/27/2017","HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREXANDA  #091632","SUPPL-17","CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX","TRIS PHARMA INC","Labeling","Approval"
"12/27/2017","CISATRACURIUM BESYLATE PRESERVATIVE FREEANDA  #200154","SUPPL-8","CISATRACURIUM BESYLATE","SANDOZ INC","Labeling","Approval"
"12/27/2017","DICLOFENAC SODIUM AND MISOPROSTOLANDA  #200540","SUPPL-3","DICLOFENAC SODIUM; MISOPROSTOL","EXELA HOLDINGS","Labeling","Approval"
"12/27/2017","DICLOFENAC SODIUM AND MISOPROSTOLANDA  #200540","SUPPL-5","DICLOFENAC SODIUM; MISOPROSTOL","EXELA HOLDINGS","Labeling","Approval"
"12/27/2017","DICLOFENAC SODIUM AND MISOPROSTOLANDA  #200540","SUPPL-6","DICLOFENAC SODIUM; MISOPROSTOL","EXELA HOLDINGS","Labeling","Approval"
"12/27/2017","GLIMEPIRIDEANDA  #202759","SUPPL-6","GLIMEPIRIDE","AUROBINDO PHARMA LTD","Labeling","Approval"
"12/27/2017","LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #203027","SUPPL-3","LEVOCETIRIZINE DIHYDROCHLORIDE","APOTEX","Labeling","Approval"
"12/27/2017","LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #203027","SUPPL-4","LEVOCETIRIZINE DIHYDROCHLORIDE","APOTEX","Labeling","Approval"
"12/27/2017","LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #203027","SUPPL-5","LEVOCETIRIZINE DIHYDROCHLORIDE","APOTEX","Labeling","Approval"
"12/27/2017","LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #203027","SUPPL-6","LEVOCETIRIZINE DIHYDROCHLORIDE","APOTEX","Labeling","Approval"
"12/27/2017","PHENDIMETRAZINE TARTRATEANDA  #203600","ORIG-1","PHENDIMETRAZINE TARTRATE","NOSTRUM LABS INC","","Approval"
"12/27/2017","LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #203646","SUPPL-6","LEVOCETIRIZINE DIHYDROCHLORIDE","SCIEGEN PHARMS INC","Labeling","Approval"
"12/27/2017","LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #203646","SUPPL-7","LEVOCETIRIZINE DIHYDROCHLORIDE","SCIEGEN PHARMS INC","Labeling","Approval"
"12/27/2017","LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #203646","SUPPL-8","LEVOCETIRIZINE DIHYDROCHLORIDE","SCIEGEN PHARMS INC","Labeling","Approval"
"12/27/2017","LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #203646","SUPPL-9","LEVOCETIRIZINE DIHYDROCHLORIDE","SCIEGEN PHARMS INC","Labeling","Approval"
"12/27/2017","JAIMIESSANDA  #203770","ORIG-1","ETHINYL ESTRADIOL; LEVONORGESTREL","XIROMED","","Approval"
"12/27/2017","FLUDEOXYGLUCOSE F18ANDA  #204264","SUPPL-1","FLUDEOXYGLUCOSE F-18","SHERTECH LABS LLC","Manufacturing (CMC)","Approval"
"12/27/2017","GABAPENTINANDA  #205101","SUPPL-5","GABAPENTIN","SCIEGEN PHARMS INC","Manufacturing (CMC)","Approval"
"12/27/2017","BUTALBITAL AND ACETAMINOPHENANDA  #207313","ORIG-1","ACETAMINOPHEN; BUTALBITAL","MAYNE PHARMA INC","","Approval"
"12/27/2017","CLOMIPRAMINE HYDROCHLORIDEANDA  #208961","ORIG-1","CLOMIPRAMINE HYDROCHLORIDE","ZYDUS PHARMS","","Approval"
"12/28/2017","CILOSTAZOLANDA  #077323","SUPPL-7","CILOSTAZOL","MYLAN","Labeling","Approval"
"12/28/2017","CILOSTAZOLANDA  #077323","SUPPL-8","CILOSTAZOL","MYLAN","Labeling","Approval"
"12/28/2017","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #209799","ORIG-1","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","NUVO PHARM","","Approval"
"12/28/2017","OXYCODONE AND ACETAMINOPHENANDA  #210079","ORIG-1","ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","NESHER PHARMS","","Approval"
"12/29/2017","THALOMIDNDA   #020785","SUPPL-65","THALIDOMIDE","CELGENE","Labeling","Approval"
"12/29/2017","REVLIMIDNDA   #021880","SUPPL-55","LENALIDOMIDE","CELGENE","Labeling","Approval"
"12/29/2017","VALACYCLOVIR HYDROCHLORIDEANDA  #079137","ORIG-1","VALACYCLOVIR HYDROCHLORIDE","CADILA","","Approval"
"12/29/2017","LAMOTRIGINEANDA  #201168","SUPPL-1","LAMOTRIGINE","ALEMBIC PHARMS LTD","Labeling","Approval"
"12/29/2017","LAMOTRIGINEANDA  #201168","SUPPL-3","LAMOTRIGINE","ALEMBIC PHARMS LTD","Labeling","Approval"
"12/29/2017","LAMOTRIGINEANDA  #201168","SUPPL-4","LAMOTRIGINE","ALEMBIC PHARMS LTD","Labeling","Approval"
"12/29/2017","POMALYSTNDA   #204026","SUPPL-19","POMALIDOMIDE","CELGENE","Labeling","Approval"
"12/29/2017","PROVAYBLUENDA   #204630","SUPPL-5","METHYLENE BLUE","PROVEPHARM SAS","Labeling","Approval"
"12/29/2017","PIROXICAMANDA  #206152","ORIG-1","PIROXICAM","MICRO LABS","","Approval"
"12/29/2017","ZOLEDRONIC ACIDANDA  #207341","ORIG-1","ZOLEDRONIC ACID","BPI LABS LLC","","Approval"
"12/29/2017","BROMFENAC SODIUMANDA  #207584","ORIG-1","BROMFENAC SODIUM","PADDOCK LABS","","Tentative Approval"
"12/29/2017","GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDEANDA  #208369","ORIG-1","GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE","DR REDDYS LABS LTD","","Approval"
"12/29/2017","ESTRADIOLANDA  #208788","ORIG-1","ESTRADIOL","MYLAN","","Approval"
"12/29/2017","GANZYK-RTUNDA   #209347","SUPPL-3","GANCICLOVIR","EXELA PHARMA","Labeling","Approval"
"12/29/2017","METHYLPHENIDATE HYDROCHLORIDEANDA  #210354","ORIG-1","METHYLPHENIDATE HYDROCHLORIDE","ASCENT PHARMS INC","","Approval"